Found 7 hits for monomerid = 50302371 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Cytochrome P450 1A
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB MMDB
Reactome pathway KEGG
B.MOAD DrugBank GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP1A2 |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C9
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP2C9 |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2C19
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 2.90E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP2C19 |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 2
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 11 | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Agonist activity at human recombinant cannabinoid CB2 receptor expressed in MMY23 Saccharomyces cerevisiae assessed as degradation of FDGlu to fluore... |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cytochrome P450 3A4
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB MMDB
Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 4.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP3A4 |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cannabinoid receptor 1
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
DrugBank antibodypedia GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | n/a | n/a | 1.00E+4 | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Agonist activity at human recombinant cannabinoid CB1 receptor expressed in MMY23 Saccharomyces cerevisiae assessed as degradation of FDGlu to fluore... |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |
Cytochrome P450 2D6
(Homo sapiens (Human)) | BDBM50302371
(1-[7-(3-Chloro-phenylamino)-3-methyl-1H-pyrrolo[2,...)Show SMILES Cc1c[nH]c2c(Nc3cccc(Cl)c3)ncc(C(=O)N3CCOCC3)c12 Show InChI InChI=1S/C19H19ClN4O2/c1-12-10-21-17-16(12)15(19(25)24-5-7-26-8-6-24)11-22-18(17)23-14-4-2-3-13(20)9-14/h2-4,9-11,21H,5-8H2,1H3,(H,22,23) | PDB
UniProtKB/SwissProt UniProtKB/TrEMBL
GoogleScholar AffyNet
| CHEMBL PC cid PC sid UniChem
Patents
Similars
| Article PubMed
| n/a | n/a | 1.40E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
GlaxoSmithKline
Curated by ChEMBL
| Assay Description Inhibition of CYP2D6 |
J Med Chem 52: 5785-8 (2009)
Article DOI: 10.1021/jm9009857 BindingDB Entry DOI: 10.7270/Q20R9PG5 |
More data for this Ligand-Target Pair | |